Most Popular in:

Medical Esthetics Treatments

Email This Item! Print This Item!

Managing Filler Complications

By: Steven H. Dayan, MD, FACS
Posted: September 1, 2010, from the September 2010 issue of
Filled syringe

page 4 of 4

Also, submit your protocols and procedures for treating fillers complications, as well as other medical aesthetic issues, to merge@allured.com to contribute to the conversation and growing community at Merge magazine.

REFERENCES
1. http://www.surgery.org/sites/default/files/2009stats.pdf (Accessed Jul 30, 2010)
2. D Cassuto, et al. Advanced laser techniques for filler-induced complications, Dermatol Surg, 35 Suppl 2 1689–1695 (Oct 2009)

FOOTNOTES
a. Vitrase is a registered trade name of ISTA Pharmaceuticals, Inc., Irvine, California.
b. Nitro-Bid is a registered trade name of E. Fougera & Co., Melville, New York.
c. Dermacyte is a registered trade name of Oxygen Biotherapeutics, Inc., Durham, North Carolina.
d. Medrol is a registered trade name of Pfizer Inc., New York.
e. Cipro is a registered trade name of Bayer AG, Leverkusen, Germany.
f. Biaxin XL is a registered trade name of Abbott Laboratories, Abbott Park, Illinois.